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Selenium status in blood, urine, and hair samples of newly
diagnosed pediatric cancer patients
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Background/aim: Selenium (Se) is a trace element that has multiple functions. Low Se amounts in serum and hair have been reported
in pediatric and adult cancer patients. The aim of our study was to evaluate Se levels in the serum, urine, and hair of pediatric cancer
patients with leukemia, lymphoma, and solid tumors when compared with healthy children.
Materials and methods: The concentrations of Se in the serum, hair, and urine of 32 Turkish children as healthy controls and 88 Turkish
children diagnosed with acute leukemia (58), lymphoma (16), and solid tumors (14) were measured using inductively coupled plasma
mass spectroscopy.
Results: Se levels in the serum and hair of the children with cancer were significantly lower than those of the controls. There were no
differences between the leukemia, lymphoma, and solid tumors group. On the other hand, the Se levels of the urine samples were slightly
elevated in cancer patients compared with the control group. There was no marked difference in the Se levels of patients with different
types of cancer.
Conclusion: Se deficiency might be associated with the development of pediatric cancer. Especially in children, additional studies are
needed to define whether low levels of Se may play a role in cancer pathogenesis.
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1. Introduction
Cancer is rare in children and adolescents. Furthermore,
it is different from adult cancers. Survival rates after
childhood cancer have improved dramatically with
intensive treatment regimens. There are many major types
and countless subtypes of cancer that respond differently
to treatment, including leukemia (cancer of the blood
cells), lymphoma (cancer of the lymphatic system), and
solid tumors (cancer of bone, organ and other tissues such
as rhabdomyosarcoma, neuroblastoma, retinoblastoma,
osteosarcoma, and renal tumors). Leukemia is the most
common type of childhood cancer, accounting for 25%
of new diagnoses. Lymphoma is a type of cancer that
originates from the lymphatic system. There are 2 main
types of lymphoma: Hodgkin’s and non-Hodgkin’s
lymphomas (1).
* Correspondence: banumansur@gmail.com

The role of different trace elements in normal vital
activities and the initiation of some disease has long
been known (2). Selenium is an important trace element
that plays a key role in protecting cells against oxidative
damage (3). Oxidative damage can lead to mutations and,
therefore, may play an important role in the initiation and
progression of carcinogenesis (4). Selenoproteins have an
anticancer effect by increasing the production of cytotoxic
T-cells and natural killer cells (5). The results of studies
about the association between selenium and adult cancer
risk have varied. Although some studies suggest that
cancer risk is associated with higher Se levels (6,7), some
studies have reported no association between Se and high
risk (8,9). There have been a few studies about the selenium
status of serum and hair in pediatric cancer (10–14), and,
to the best of our knowledge, this is the first study about
urine selenium status in pediatric cancer patients.
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The aim of this study was to evaluate Se status in
serum, hair, and urine samples of newly diagnosed
pediatric leukemia, lymphoma, and solid tumor patients
and to investigate the probability of a relationship between
Se levels and the progression of pediatric cancer.
2. Materials and methods
Between January 2012 and December 2013, 88 pediatric
patients with newly diagnosed cancer including acute
leukemia (n = 58), Hodgkin’s lymphoma (n = 4), nonHodgkin’s lymphoma (n = 12), and solid tumors (5
neuroblastoma, 5 medulloblastoma, 1 Wilms’ tumor,
1 hepatoblastoma, 1 rhabdomyosarcoma, and 1
osteosarcoma) were admitted to the Pediatric Hematology–
Oncology Division at Şişli Etfal Education and Training
Hospital. Furthermore, 32 age- and sex-matched healthy
children (brothers or sisters of patients) were enrolled in
the study as the control group. All children belonged to
middle class families and informed consent was obtained
for all children from their parents.
There were 51 male and 37 female (mean age: 6.79 ±
3.88 years) in the study group and 19 male and 13 female
(mean age: 6.52 ± 2.52 years) in the healthy control group.
There were no statistical differences between the two
groups regarding age and socioeconomic status.
This study was approved by the Ethics Committee of
the Şişli Etfal Education and Training Hospital. Signed
informed content was obtained from all participants’
parents at the beginning of the study.
2.1. Biological sample collection and storage
Blood, urine, and hair samples were taken from 32
controls and 88 cancer patients (leukemia or solid tumors)
diagnosed in the Pediatric Hematology–Oncology Clinic
of Şişli Etfal Education and Training Hospital.
Approximately 2 mL of venous blood was collected
from each of the 120 children using sterile syringes and
needles. The samples were put into heparinized pretreated
clean polypropylene tubes, carefully avoiding external
metal contamination and hemolysis.
Hair samples were collected by clipping hair from
the back of the head and near the scalp with stainlesssteel scissors and putting the clippings into clean plastic
bags. Blood and urine measurements were obtained
from patients and controls at 0800 hours. Serum was
separated with centrifugation at 3500 rpm and stored at
–80 °C. Selenium levels were determined using inductively
coupled plasma mass spectroscopy (ICP-MS).
All biological samples were dissolved with a microwave
device for metal analyses and the metal analyses of the
biological samples were performed with ICP-MS. The
amount of selenium metal in all samples was determined.
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2.2. Standard solutions
Metal stock solutions of 1000 mg/L were used as standards
and prepared by dilution with deionized distilled water.
Calibration of the ICP-MS instrument was done with this
solution produced by Merck. Solutions were prepared for
ICP-MS at suitable concentrations for analysis.
Prior to use, all plastic and glass equipment was
washed with detergent and distilled water and then
washed with a 10% HNO3 solution. Finally, deionized
water was used. Only chemicals used in analytical purity
assays and ultrapure water were used in the preparation of
the solutions.
2.3. Instruments
A PerkinElmer Sciex Elan DRC-e model inductively
coupled plasma mass spectrometer was used for metal
analysis and a Milestone Ethos 900 brand of microwave
dissolution device was used for sample preparation.
2.4. Sample preparation with microwave oven
Biological samples were dissolved in the Milestone Ethos
900 microwave device in 100-mL Teflon containers. Next,
1 g of each sample was placed into a sample cup in the
device. Then 6 mL of 65% HNO3 and 3 mL of 30% H2O2
were added to each biological sample.
Sealed containers were placed into the microwave
device and the dissolution procedure was performed, with
the process being 4 min at 250 W, 5 min at 400 W, 4 min
at 250 W, 5 min at 400 W, 6 min at 550 W, and 8 min of
ventilation. After the dissolution time, the containers were
kept at room temperature for cooling. Then the cups were
removed, the contents of cups were added to 50-mL flasks,
and the volume of each flask was filled to 50 mL with
bidistilled water.
2.5. Spectroscopic analyses
ICP-MS is an analytical technique that breaks molecular
bonds and ionizes atoms of samples by using a high
temperature plasma, usually argon. Ions are sent into the
samples and the second stage of the vacuum through a
cone interface. Here, a coupled lens system focuses the
ions to quadruple the mass spectrometer. Then, the ions
are sorted by mass and analyzed by a scanning electron
multiplier. Samples are generally sent into the device
as a solution through a nebulizer. ICP-MS can measure
different masses very quickly, which is why it was used as
the multi-element analysis technique in this study.
2.6. Statistical analysis
Data were expressed as mean ± standard deviation for
each group. A nonparametric analysis was carried out on
the Se level data with a Mann–Whitney U test to examine
the differences between the control and all patient
groups. P values less than 0.05 (P < 0.05) were accepted
as significant. All statistical analyses were performed using
SPSS 15.0 (15).
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3. Results
Characteristics of the study and control groups are given
in Table 1. The study included 88 Turkish patients with
different malignancies (51 male and 37 female, mean age:
6.79 ± 3.88 years) and 32 Turkish healthy children (19 male
and 13 female, mean age: 6.52 ± 2.52 years). The age range
of the subjects varied from 0.5 to 16 years. There were no
significant differences regarding environmental exposure
during pregnancy in terms of maternal exposure to
vaccination, smoke, passive smoke, tattoos, and pesticides.
The patients did not differ significantly from the healthy
children in terms of age, sex, body mass index, sleep
problems, and nutrition (types of food, milk, and meat).
The Se concentration results of both the control and
patient groups and a comparison of serum Se levels are
presented in Table 2. The mean Se levels were 162.62 ±
26.38 µg/L, 154.00 ± 30.64 µg/L, 147.75 ± 16.34 µg/L, and
202.37 ± 21.45 µg/L for the leukemia, lymphoma, solid
tumor, and control groups, respectively. The serum Se levels
of the 3 cancer patients groups were significantly lower in
comparison to those of the healthy children (P < 0.001, P
< 0.011, and P < 0.001 for the leukemia, lymphoma, and
solid tumor groups, respectively). However, there were no
statistically significant differences among the three cancer
subtypes (data not shown).
Since selenium is excreted mainly via the urine, a urine
analysis is important for assessing Se status in children
(16). Table 3 summarizes the Se concentration in the

urine of both the control and patient groups and gives a
comparison of urine Se levels. The mean levels of urine Se
were slightly elevated for cancer patients compared to the
control, at 72.65 ± 14.95 µg/L, 73.53 ± 11.04 µg/L, 75.61
± 12.25 µg/L, and 59.84 ± 13.40 µg/L for the leukemia,
lymphoma, solid tumor, and control groups, respectively.
Differences between the control and patients groups
were statistically significant at P < 0.017, P < 0.029, and
P < 0.010 for the leukemia, lymphoma, and solid tumor
groups, respectively. However, there were no statistically
significant differences among the cancer subtypes (data
not shown).
Hair Se levels for the whole group of hematologic
malignancies and the control group are shown in Table
4. The mean values for hair Se concentration of patients
were reduced compared to the control group, at 0.47 ± 0.16
ng/g for leukemia patients (P < 0.048), 0.49 ± 0.17 ng/g
for lymphoma patients (P < 0.095), 0.45 ± 0.12 ng/g for
solid tumor patients (P < 0.027), and 0.63 ± 0.2 for the
control group. Although the hair Se level was lower for
lymphoma patients than the control group, this difference
was not statistically significant (P < 0.095). In contrast, the
Se levels for both the leukemia (P < 0.048) and solid tumor
(P < 0.027) groups were significantly lower than those for
the control group, but there was no statistically significant
difference among the malignancies subtypes according to
hair Se level (data not shown).

Table 1. Demographic characteristics of the patient and control groups.
Patients

Control

Number

88

32

Age, years (mean ± standard deviation, min–max)

6.79 ± 3.88 (0.5–16)

6.52 ± 2.52 (3–15)

Female

37 → 42.05%

13 → 40.6%

Male

51 → 57.95%

19 → 59.4%

Any other disease

No

No

Vitamin-mineral supplementation (yes/no)

No

No

Malnutrition

No

No

Normal body mass indices (BMI) (yes/no)

Yes

Yes

Leukemia

58/88

-

Lymphoma

16/88

-

Solid tumor

14/88

-

Gender (female/male)

Hematologic malignancies subtype
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Table 2. Serum selenium levels of the patient and control groups.
Patient

Control

P value*

Serum Se level (µg/L)
Leukemia (n = 25)

162.62 ± 26.38

Lymphoma (n = 13)

154.00 ± 30.64

Solid tumor (n = 2)

147.75 ± 16.34

0.001
202.37 ± 21.45

0.011
0.001

Se = selenium; data are expressed as mean ± SD; * = Mann–Whitney U test.
Table 3. Urine selenium levels of the patient and control groups.
Patient

Control

P value*

Urine Se level (µg/L)
Leukemia (n = 25)

73.53 ± 11.04

Lymphoma (n = 13)

72.65 ± 14.95

Solid tumor (n = 2)

75.61 ± 12.25

0.017
59.84 ± 13.40

0.029
0.010

Se = selenium; data are expressed as mean ± SD; * = Mann–Whitney U test.
Table 4. Hair selenium levels of the patient and control groups.
Patient

Control

P value*

Hair Se level (ng/g)
Leukemia (n = 16)

0.47 ± 0.16

Lymphoma (n = 16)

0.49 ± 0.17

Solid tumor (n = 16)

0.45 ± 0.12

0.048
0.63 ± 0.20

0.095
0.027

Se = selenium; data are expressed as mean ± SD; * = Mann–Whitney U test.

4. Discussion
Pediatric cancer affects all ethnic and socioeconomic
groups. Increased cancer rates in children have been
associated with inherited predisposition, radiation,
electromagnetic fields, chemicals, and viral infections.
Selenium is a trace element that protects cells against
oxidative stress. In general, the pediatric population is
considered more likely to be at risk for selenium deficiency
due to the diversity of food quality and intake after birth,
including sex, geological, and geochemical factors (i.e.
drinking water and locally produced food). Selenium
levels are expected to be much more heterogeneous in
childhood than in an adult population. Leukemia is a
malignant disease that is susceptible to antioxidant enzyme
and essential elements alterations. Low Se levels have been
reported in pediatric cancer patients (10–14,17).
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In mineral/trace element deficiency, biological samples
such as blood, urine, and hair (18) are most often used for
biological monitoring. Whole blood, serum, and urine
levels may show variability throughout a day; however,
unlike blood serum and urine, hair provides historical
information about intracellular accumulations and
concentrations of trace elements in the body as well as
nutritional condition over a long time (19–21).
In our study, we investigated the Se levels of the serum,
urine, and hair of children with leukemia, lymphoma, and
solid tumors. Selenium is a trace element that plays an
important role in the protection against oxidative stress
in cells. Oxidative stress produces free radicals, which are
involved in the pathogenesis of many diseases including
hematologic malignancy (5).
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The relationship between the trace element Se and the
etiology of cancer remains contentious and interesting,
despite the large number of published epidemiologic
studies (10). Although selenium levels in plasma, serum,
or whole blood samples reflect a short-term index of
selenium status, hair selenium concentrations give
information about long-term selenium status due to its
slower turnover rate.
There have been several reports regarding decreased
blood Se levels of adult cancer patients (5,13,22);
however, there have been a limited number of studies
that investigated Se status in childhood malignancies
(10–14,17,23). Different hypotheses are suggested for
explaining the relation between reduced Se levels and
hematologic malignancies (10). The first hypothesis states
that enhanced uptake of selenium by the neoplastic tissue
might be responsible for depleting the trace element
content in the blood and other tissues. Thereby, serum
selenium concentrations are reduced (24). Secondly, the

reduced Se concentration with disease progression might
be due to dietary changes (10,24).
In conclusion, the present study gives support to the
hypothesis of the relationship between Se concentrations
in serum, urine, and hair samples of newly diagnosed
pediatric cancer patients. We found a significant Se
deficiency related to leukemia, lymphoma, and solid
tumor cancer subtypes. Our overall results suggest the
importance of low Se status and the presence of an
oxidant/antioxidant imbalance in childhood hematologic
malignancies. The relationship between Se deficiency
and childhood hematologic malignancies needs to be
confirmed in further studies.
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